NCT07563205 Observational Multicenter Study in Patients Receiving Chemotherapy and Amivantamab for Metastatic Non-small Cell Lung Cancer Status RECRUITING Phase N/A
NCT07559123 Imaging-based PRediction of Eligibility for ChemoImmunotherapy in reSEctable NSCLC, iPRECISE Status RECRUITING Phase N/A
NCT07550920 Relatrilfa-α Plus Single-Agent Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III NSCLC (Phase 2) Status NOT_YET_RECRUITING Phase PHASE2
NCT07530744 Post-Market Registry of Transbronchial Cryo-assisted RFA During Routine Standard Bronchoscopic Tumor Stagng and Resection Status NOT_YET_RECRUITING Phase NA
NCT07530276 A Prospective Observational Study of Changes in Cortisol Levels After Neoadjuvant Immunotherapy and Their Prognostic Value in Patients With NSCLC Status ACTIVE_NOT_RECRUITING Phase N/A
NCT07516015 Clinical Effectiveness and Safety of SHR-A1811 in Chinese Patients With HER2-Altered NSCLC Status NOT_YET_RECRUITING Phase N/A
NCT07479277 Progel Platinum for Air Leak Reduction After VATS Lobectomy for NSCLC Status RECRUITING Phase NA
NCT07413952 Limertinib Plus Radiotherapy for EGFR-Mutant NSCLC With Brain Metastases Status NOT_YET_RECRUITING Phase PHASE2
NCT07412041 Precise Exercise Regimen for Cancer Care (PERCC): A Pilot Study Status NOT_YET_RECRUITING Phase NA
NCT07397338 Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT07388771 Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer(NSCLC) Status RECRUITING Phase N/A
NCT07379398 Iparomlimab and Tuvonralimab Injection Combined With SBRT in Patients With Early-Stage Non-Small Cell Lung Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT07376382 A Phase Ⅲ Clinical Study of SYS6010 in Combination With Osimertinib in Patients With Locally Advanced or Metastatic NSCLC Status NOT_YET_RECRUITING Phase PHASE3
NCT07358689 Toripalimab Combined With Platinum-based Chemotherapy With or Without H1 Receptor Antagonist in the Perioperative Treatment of Resectable Non-small Cell Lung Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT07349537 Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors Status RECRUITING Phase PHASE1
NCT07330076 Iruplinalkib Tablets as Postoperative Adjuvant Therapy in Stage IA ALK-positive NSCLC With High-risk Factors Status NOT_YET_RECRUITING Phase PHASE2
NCT07330037 TALENT Study: Phase II Trial of Adjuvant L-TIL Plus Tislelizumab in Resectable NSCLC Without pCR After Neoadjuvant Chemoimmunotherapy Status RECRUITING Phase PHASE2
NCT07325864 Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site Status RECRUITING Phase N/A
NCT07323732 A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease Status RECRUITING Phase PHASE2
NCT07286942 Stereotactic Body Radiotherapy With Sequential Iparomlimab and Tuvonralimab (QL1706) + Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Non-small-cell Lung Cancer in China (LUNG-Nanjing01): a Single-arm, Single-centre, Phase 2 Trial Status NOT_YET_RECRUITING Phase PHASE2